サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1089216

メソセラピーの世界市場 (2022年)

Global Mesotherapy Market Research Report 2022
出版日: | 発行: QYResearch | ページ情報: 英文 110 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.86円
メソセラピーの世界市場 (2022年)
出版日: 2022年06月15日
発行: QYResearch
ページ情報: 英文 110 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のメソセラピーの市場規模は、2021年には6億8,969万米ドル、2028年には12億1,589万米ドルに達する見通しです。

また、2022年から2028年の間に7.94%のCAGRで成長すると予測されています。

当レポートでは、世界のメソセラピーの市場について分析し、種類別・用途別・地域別 (国別) の市場動向の見通し (2017年～2028年)、主要企業のプロファイルなどについて調査しております。

目次

第1章 メソセラピー：市場概要

  • メソセラピー：製品の概要と範囲
  • 種類別のセグメント
    • 販売成長率の比較：種類別 (2022年～2028年)
    • 基本的メソセラピー
    • 複合メソセラピー
    • マイクロニードル
    • その他
  • 用途別のセグメント
    • 販売の比較：用途別 (2022年～2028年)
    • 病院
    • 診療所
    • 美容クリニック
    • その他
  • 世界のメソセラピーの市場規模：推定・予測
    • 収益：推定・予測 (2017年～2028年)
    • 販売：推定・予測 (2017年～2028年)
    • 市場規模：地域別 (2017年・2021年・2028年)

第2章 メソセラピー：メーカー別の市場競争

  • 販売・市場シェア：メーカー別 (2017年～2022年)
  • 収益・市場シェア：メーカー別 (2017年～2022年)
  • 平均価格：メーカー別 (2017年～2022年)
  • メソセラピーメーカーの製造拠点・提供エリア
  • メソセラピー市場の競争状況と動向

第3章 メソセラピー市場：地域別の遡及的シナリオ

  • 販売の遡及的シナリオ：地域別 (2017年～2022年)
  • 収益の遡及的シナリオ：地域別 (2017年～2022年)
  • 北米のメソセラピー市場：国別の詳細分析
    • 米国
    • カナダ
    • メキシコ
  • 欧州のメソセラピー市場：国別の詳細分析
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
  • アジア太平洋のメソセラピー市場：地域別の詳細分析
    • 中国
    • 日本
    • 韓国
  • 南米のメソセラピー市場：国別の詳細分析
    • ブラジル
  • 中東・アフリカのメソセラピー市場：国別の詳細分析
    • 中東
    • アフリカ

第4章 メソセラピー：過去の市場分析、種類別

  • 販売・市場シェア：種類別 (2017年～2022年)
  • 収益・市場シェア：種類別 (2017年～2022年)
  • 価格：種類別 (2017年～2022年)

第5章 メソセラピー：過去の市場分析、用途別

  • 販売・市場シェア：用途別 (2017年～2022年)
  • 収益・市場シェア：用途別 (2017年～2022年)
  • 価格：用途別 (2017年～2022年)

第6章 主要企業のプロファイル

  • FILORGA
    • 企業情報
    • 企業概略・事業概要
    • 販売・収益・粗利益 (2017年～2022年)
    • 製品ポートフォリオ
    • 昨今の動向
  • TEOXANE
  • ALLERGAN
  • BENEV SKINCARE
  • TEVAPHARM
  • CHAMEDITHEC
  • DONG KOOK LIFESCIENCE
  • HUONS
  • BLOOMAGEFREDA
  • SHANGHAI QISHENG
  • EVE CHARM
  • PAVAY
  • SUNMAX BIOTECH
  • IMEIK

第7章 メソセラピーの製造コストの分析

  • メソセラピーの主要原材料の分析
  • 製造コストの構造比率
  • メソセラピーの製造プロセスの分析
  • メソセラピーの産業チェーンの分析

第8章 マーケティングチャネル・流通業者・顧客

  • マーケティングチャネル
  • メソセラピーの流通業者の一覧
  • メソセラピーの顧客

第9章 メソセラピー市場：市場力学

  • メソセラピー業界の動向
  • メソセラピー市場の促進要因
  • メソセラピー市場の課題
  • メソセラピー市場の抑制要因

第10章 世界市場の予測

  • メソセラピー市場：種類別の推計・予測
    • 販売予測：種類別 (2023年～2028年)
    • 収益予測：種類別 (2023年～2028年)
  • メソセラピー市場：用途別の推計・予測
    • 販売予測：用途別 (2023年～2028年)
    • 収益予測：用途別 (2023年～2028年)
  • メソセラピー市場：地域別の推計・予測
    • 販売予測：地域別 (2023年～2028年)
    • 収益予測：地域別 (2023年～2028年)

第11章 調査結果と結論

第12章 調査手法とデータソース

図表

LIST OF TABLES

  • Table 1. Product Picture of Mesotherapy
  • Table 2. Global Mesotherapy Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
  • Table 3. Global Mesotherapy Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
  • Table 4. Global Mesotherapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 5. Global Mesotherapy Market Competitive Situation by Manufacturers in 2021
  • Table 6. Global Mesotherapy Sales (K Units) of Key Manufacturers (2017-2022)
  • Table 7. Global Mesotherapy Sales Market Share by Manufacturers (2017-2022)
  • Table 8. Global Mesotherapy Revenue (US$ Million) by Manufacturers (2017-2022)
  • Table 9. Global Mesotherapy Revenue Share by Manufacturers (2017-2022)
  • Table 10. Global Market Mesotherapy Average Price (US$/Unit) of Key Manufacturers (2017-2022)
  • Table 11. Manufacturers Mesotherapy Manufacturing Sites and Area Served
  • Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 13. Global Mesotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesotherapy as of 2021)
  • Table 14. Global Mesotherapy Sales by Region (2017-2022) & (K Units)
  • Table 15. Global Mesotherapy Sales Market Share by Region (2017-2022)
  • Table 16. Global Mesotherapy Revenue by Region (2017-2022) & (US$ Million)
  • Table 17. Global Mesotherapy Revenue Market Share by Region (2017-2022)
  • Table 18. North America Mesotherapy Sales by Country (2017-2022) & (K Units)
  • Table 19. North America Mesotherapy Sales Market Share by Country (2017-2022)
  • Table 20. North America Mesotherapy Revenue by Country (2017-2022) & (US$ Million)
  • Table 21. North America Mesotherapy Revenue Market Share by Country (2017-2022)
  • Table 22. Europe Mesotherapy Sales by Country (2017-2022) & (K Units)
  • Table 23. Europe Mesotherapy Sales Market Share by Country (2017-2022)
  • Table 24. Europe Mesotherapy Revenue by Country (2017-2022) & (US$ Million)
  • Table 25. Europe Mesotherapy Revenue Market Share by Country (2017-2022)
  • Table 26. Asia Pacific Mesotherapy Sales by Region (2017-2022) & (K Units)
  • Table 27. Asia Pacific Mesotherapy Sales Market Share by Region (2017-2022)
  • Table 28. Asia Pacific Mesotherapy Revenue by Region (2017-2022) & (US$ Million)
  • Table 29. Asia Pacific Mesotherapy Revenue Market Share by Region (2017-2022)
  • Table 30. South America Mesotherapy Sales by Country (2017-2022) & (K Units)
  • Table 31. South America Mesotherapy Sales Market Share by Country (2017-2022)
  • Table 32. South America Mesotherapy Revenue by Country (2017-2022) & (US$ Million)
  • Table 33. South America Mesotherapy Revenue Market Share by Country (2017-2022)
  • Table 34. Middle East and Africa Mesotherapy Sales by Country (2017-2022) & (K Units)
  • Table 35. Middle East and Africa Mesotherapy Sales Market Share by Country (2017-2022)
  • Table 36. Middle East and Africa Mesotherapy Revenue by Country (2017-2022) & (US$ Million)
  • Table 37. Middle East and Africa Mesotherapy Revenue Market Share by Country (2017-2022)
  • Table 38. Global Mesotherapy Sales by Type (2017-2022) & (K Units)
  • Table 39. Global Mesotherapy Sales Market Share by Type (2017-2022)
  • Table 40. Global Mesotherapy Revenue by Type (2017-2022) & (US$ Million)
  • Table 41. Global Mesotherapy Revenue Share by Type (2017-2022)
  • Table 42. Global Mesotherapy Price by Type (2017-2022) & (US$/Unit)
  • Table 43. Global Mesotherapy Sales (K Units) by Application (2017-2022)
  • Table 44. Global Mesotherapy Sales Market Share by Application (2017-2022)
  • Table 45. Global Mesotherapy Revenue by Application (2017-2022) & (US$ Million)
  • Table 46. Global Mesotherapy Revenue Share by Application (2017-2022)
  • Table 47. Global Mesotherapy Price by Application (2017-2022) & (US$/Unit)
  • Table 48. Filorga Corporation Information
  • Table 49. Filorga Description and Business Overview
  • Table 50. Filorga Mesotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 51. Filorga Mesotherapy Product
  • Table 52. Filorga Recent Developments/Updates
  • Table 53. Teoxane Corporation Information
  • Table 54. Teoxane Description and Business Overview
  • Table 55. Teoxane Mesotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 56. Teoxane Mesotherapy Product
  • Table 57. Allergan Corporation Information
  • Table 58. Allergan Description and Business Overview
  • Table 59. Allergan Mesotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 60. Allergan Mesotherapy Product
  • Table 61. Benev Skincare Corporation Information
  • Table 62. Benev Skincare Description and Business Overview
  • Table 63. Benev Skincare Mesotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 64. Tevapharm Corporation Information
  • Table 65. Tevapharm Description and Business Overview
  • Table 66. Tevapharm Mesotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 67. CHAMEDITHEC Corporation Information
  • Table 68. CHAMEDITHEC Mesotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 69. Dong Kook Lifescience Corporation Information
  • Table 70. Dong Kook Lifescience Description and Business Overview
  • Table 71. Dong Kook Lifescience Mesotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 72. Huons Corporation Information
  • Table 73. Huons Description and Business Overview
  • Table 74. Huons Mesotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 75. Bloomagefreda Corporation Information
  • Table 76. Bloomagefreda Description and Business Overview
  • Table 77. Bloomagefreda Mesotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 78. Shanghai Qisheng Corporation Information
  • Table 79. Shanghai Qisheng Description and Business Overview
  • Table 80. Shanghai Qisheng Mesotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 81. EVE CHARM Corporation Information
  • Table 82. EVE CHARM Description and Business Overview
  • Table 83. EVE CHARM Mesotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 84. Pavay Corporation Information
  • Table 85. Pavay Description and Business Overview
  • Table 86. Pavay Mesotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 87. Sunmax Biotech Corporation Information
  • Table 88. Sunmax Biotech Mesotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 89. Sunmax Biotech Mesotherapy Product
  • Table 90. Imeik Corporation Information
  • Table 91. Imeik Description and Business Overview
  • Table 92. Imeik Mesotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 93. Key Suppliers of Raw Materials
  • Table 94. Mesotherapy Distributors List
  • Table 95. Mesotherapy Market Trends
  • Table 96. Mesotherapy Market Drivers
  • Table 97. Mesotherapy Market Challenges
  • Table 98. Mesotherapy Market Restraints
  • Table 99. Global Mesotherapy Sales Forecast by Type (2023-2028) & (K Units)
  • Table 100. Global Mesotherapy Sales Market Share Forecast by Type (2023-2028)
  • Table 101. Global Mesotherapy Revenue Forecast by Type (2023-2028) & (US$ Million)
  • Table 102. Global Mesotherapy Revenue Market Share Forecast by Type (2023-2028)
  • Table 103. Global Mesotherapy Sales Forecast by Application (2023-2028) & (K Units)
  • Table 104. Global Mesotherapy Sales Market Share Forecast by Application (2023-2028)
  • Table 105. Global Mesotherapy Revenue Forecast by Application (2023-2028) & (US$ Million)
  • Table 106. Global Mesotherapy Revenue Market Share Forecast by Application (2023-2028)
  • Table 107. Global Mesotherapy Sales Forecast by Region (2023-2028) & (K Units)
  • Table 108. Global Mesotherapy Sales Market Share Forecast by Region (2023-2028)
  • Table 109. Global Mesotherapy Revenue Forecast by Region (2023-2028) & (US$ Million)
  • Table 110. Global Mesotherapy Revenue Market Share Forecast by Region (2023-2028)
  • Table 111. Research Programs/Design for This Report
  • Table 112. Key Data Information from Secondary Sources
  • Table 113. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Mesotherapy Market Share by Type: 2022 & 2028
  • Figure 2. Global Mesotherapy Market Share by Application: 2022 & 2028
  • Figure 3. Hospital
  • Figure 4. Clinic
  • Figure 5. Beauty Agency
  • Figure 6. Global Mesotherapy Revenue, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 7. Global Mesotherapy Market Size (2017-2028) & (US$ Million)
  • Figure 8. Global Mesotherapy Sales (2017-2028) & (K Units)
  • Figure 9. Mesotherapy Sales Share by Manufacturers in 2021
  • Figure 10. Global Mesotherapy Revenue Share by Manufacturers in 2021
  • Figure 11. Global 5 and 10 Largest Mesotherapy Players: Market Share by Revenue in Mesotherapy in 2021
  • Figure 12. North America Mesotherapy Sales Market Share by Country in 2021
  • Figure 13. U.S. Mesotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 14. Canada Mesotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 15. Mexico Mesotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 16. Germany Mesotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 17. France Mesotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 18. U.K. Mesotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 19. Italy Mesotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 20. Spain Mesotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 21. China Mesotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 22. Japan Mesotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 23. South Korea Mesotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 24. Brazil Mesotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 25. Middle East Mesotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 26. Africa Mesotherapy Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 27. Sales Market Share of Mesotherapy by Type (2017-2022)
  • Figure 28. Benev Skincare Mesotherapy Product
  • Figure 29. Tevapharm Mesotherapy Product
  • Figure 30. CHAMEDITHEC Description and Business Overview
  • Figure 31. CHAMEDITHEC Mesotherapy Product
  • Figure 32. Dong Kook Lifescience Mesotherapy Product
  • Figure 33. Huons Mesotherapy Product
  • Figure 34. Cytocare Mesotherapy Product
  • Figure 35. Bloomagefreda Mesotherapy Product
  • Figure 36. Shanghai Qisheng Mesotherapy Product
  • Figure 37. EVE CHARM Mesotherapy Product
  • Figure 38. Pavay Mesotherapy Product
  • Figure 39. Imeik Mesotherapy Product
  • Figure 40. Manufacturing Cost Structure of Mesotherapy
  • Figure 41. Manufacturing Process Analysis of Hyaluronic Acid Mesotherapy
  • Figure 42. Mesotherapy Industrial Chain Analysis
  • Figure 43. Channels of Distribution
  • Figure 44. Distributors Profiles
  • Figure 45. Bottom-up and Top-down Approaches for This Report
  • Figure 46. Data Triangulation
  • Figure 47. Key Executives Interviewed
目次

In 2021, the global Mesotherapy market size was US$ 689.69 million and it will reach US$ 1,215.89 million in 2028, growing at CAGR of 7.94% between 2022 and 2028.

This report focuses on Mesotherapy volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Mesotherapy market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan, South Korea, etc.

Segment Analysis:

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment Analysis:

The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2017 to 2028. by Application segment also provides consumption during the forecast period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

By Company

  • Filorga
  • Teoxane
  • Allergan
  • Benev Skincare
  • Tevapharm
  • CHAMEDITHEC
  • Dong Kook Lifescience
  • Huons
  • Bloomagefreda
  • Shanghai Qisheng
  • EVE CHARM
  • Pavay
  • Sunmax Biotech
  • Imeik

Segment by Type

  • Basic Mesotherapy
  • Compound Mesotherapy
  • Micro Needle
  • Other

Segment by Application

  • Hospital
  • Clinic
  • Beauty Agency
  • Other

Consumption by Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • Japan
    • South Korea
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Rest of South America

TABLE OF CONTENTS

1 MESOTHERAPY MARKET OVERVIEW

  • 1.1 PRODUCT OVERVIEW AND SCOPE OF MESOTHERAPY
  • 1.2 MESOTHERAPY SEGMENT BY TYPE
    • 1.2.1 GLOBAL MESOTHERAPY SALES GROWTH RATE COMPARISON BY TYPE (2022-2028)
    • 1.2.2 BASIC MESOTHERAPY
    • 1.2.3 COMPOUND MESOTHERAPY
    • 1.2.4 MICRO NEEDLE
    • 1.2.5 OTHER
  • 1.3 MESOTHERAPY SEGMENT BY APPLICATION
    • 1.3.1 GLOBAL MESOTHERAPY SALES COMPARISON BY APPLICATION (2022-2028)
    • 1.3.2 HOSPITAL
    • 1.3.3 CLINIC
    • 1.3.4 BEAUTY AGENCY
    • 1.3.5 OTHER
  • 1.4 GLOBAL MESOTHERAPY MARKET SIZE ESTIMATES AND FORECASTS
    • 1.4.1 GLOBAL MESOTHERAPY REVENUE 2017-2028
    • 1.4.2 GLOBAL MESOTHERAPY SALES 2017-2028
    • 1.4.3 MESOTHERAPY MARKET SIZE BY REGION: 2017 VERSUS 2021 VERSUS 2028

2 MESOTHERAPY MARKET COMPETITION BY MANUFACTURERS

  • 2.1 GLOBAL MESOTHERAPY SALES MARKET SHARE BY MANUFACTURERS (2017-2022)
  • 2.2 GLOBAL MESOTHERAPY REVENUE MARKET SHARE BY MANUFACTURERS (2017-2022)
  • 2.3 GLOBAL MESOTHERAPY AVERAGE PRICE BY MANUFACTURERS (2017-2022)
  • 2.4 MANUFACTURERS MESOTHERAPY MANUFACTURING SITES, AREA SERVED
  • 2.5 MESOTHERAPY MARKET COMPETITIVE SITUATION AND TRENDS
    • 2.5.1 MESOTHERAPY MARKET CONCENTRATION RATE
    • 2.5.2 THE GLOBAL 5 AND 10 LARGEST MESOTHERAPY PLAYERS MARKET SHARE BY REVENUE
    • 2.5.3 GLOBAL MESOTHERAPY MARKET SHARE BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3)

3 MESOTHERAPY RETROSPECTIVE MARKET SCENARIO BY REGION

  • 3.1 GLOBAL MESOTHERAPY RETROSPECTIVE MARKET SCENARIO IN SALES BY REGION: 2017-2022
  • 3.2 GLOBAL MESOTHERAPY RETROSPECTIVE MARKET SCENARIO IN REVENUE BY REGION: 2017-2022
  • 3.3 NORTH AMERICA MESOTHERAPY MARKET FACTS & FIGURES BY COUNTRY
    • 3.3.1 NORTH AMERICA MESOTHERAPY SALES BY COUNTRY
    • 3.3.2 NORTH AMERICA MESOTHERAPY REVENUE BY COUNTRY
    • 3.3.3 U.S.
    • 3.3.4 CANADA
    • 3.3.5 MEXICO
  • 3.4 EUROPE MESOTHERAPY MARKET FACTS & FIGURES BY COUNTRY
    • 3.4.1 EUROPE MESOTHERAPY SALES BY COUNTRY
    • 3.4.2 EUROPE MESOTHERAPY REVENUE BY COUNTRY
    • 3.4.3 GERMANY
    • 3.4.4 FRANCE
    • 3.4.5 U.K.
    • 3.4.6 ITALY
    • 3.4.7 SPAIN
  • 3.5 ASIA PACIFIC MESOTHERAPY MARKET FACTS & FIGURES BY REGION
    • 3.5.1 ASIA PACIFIC MESOTHERAPY SALES BY REGION
    • 3.5.2 ASIA PACIFIC MESOTHERAPY REVENUE BY REGION
    • 3.5.3 CHINA
    • 3.5.4 JAPAN
    • 3.5.5 SOUTH KOREA
  • 3.6 SOUTH AMERICA MESOTHERAPY MARKET FACTS & FIGURES BY COUNTRY
    • 3.6.1 SOUTH AMERICA MESOTHERAPY SALES BY COUNTRY
    • 3.6.2 SOUTH AMERICA MESOTHERAPY REVENUE BY COUNTRY
    • 3.6.3 BRAZIL
  • 3.7 MIDDLE EAST AND AFRICA MESOTHERAPY MARKET FACTS & FIGURES BY COUNTRY
    • 3.7.1 MIDDLE EAST AND AFRICA MESOTHERAPY SALES BY COUNTRY
    • 3.7.2 MIDDLE EAST AND AFRICA MESOTHERAPY REVENUE BY COUNTRY
    • 3.7.3 MIDDLE EAST
    • 3.7.4 AFRICA

4 MESOTHERAPY HISTORIC MARKET ANALYSIS BY TYPE

  • 4.1 GLOBAL MESOTHERAPY SALES MARKET SHARE BY TYPE (2017-2022)
  • 4.2 GLOBAL MESOTHERAPY REVENUE MARKET SHARE BY TYPE (2017-2022)
  • 4.3 GLOBAL MESOTHERAPY PRICE BY TYPE (2017-2022)

5 MESOTHERAPY HISTORIC MARKET ANALYSIS BY APPLICATION

  • 5.1 GLOBAL MESOTHERAPY SALES MARKET SHARE BY APPLICATION (2017-2022)
  • 5.2 GLOBAL MESOTHERAPY REVENUE MARKET SHARE BY APPLICATION (2017-2022)
  • 5.3 GLOBAL MESOTHERAPY PRICE BY APPLICATION (2017-2022)

6 KEY COMPANIES PROFILED

  • 6.1 FILORGA
    • 6.1.1 FILORGA CORPORATION INFORMATION
    • 6.1.2 FILORGA DESCRIPTION AND BUSINESS OVERVIEW
    • 6.1.3 FILORGA MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.1.4 FILORGA MESOTHERAPY PRODUCT PORTFOLIO
    • 6.1.5 FILORGA RECENT DEVELOPMENTS/UPDATES
  • 6.2 TEOXANE
    • 6.2.1 TEOXANE CORPORATION INFORMATION
    • 6.2.2 TEOXANE DESCRIPTION AND BUSINESS OVERVIEW
    • 6.2.3 TEOXANE MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.2.4 TEOXANE MESOTHERAPY PRODUCT PORTFOLIO
  • 6.3 ALLERGAN
    • 6.3.1 ALLERGAN CORPORATION INFORMATION
    • 6.3.2 ALLERGAN DESCRIPTION AND BUSINESS OVERVIEW
    • 6.3.3 ALLERGAN MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.3.4 ALLERGAN MESOTHERAPY PRODUCT PORTFOLIO
  • 6.4 BENEV SKINCARE
    • 6.4.1 BENEV SKINCARE CORPORATION INFORMATION
    • 6.4.2 BENEV SKINCARE DESCRIPTION AND BUSINESS OVERVIEW
    • 6.4.3 BENEV SKINCARE MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.4.4 BENEV SKINCARE MESOTHERAPY PRODUCT PORTFOLIO
  • 6.5 TEVAPHARM
    • 6.5.1 TEVAPHARM CORPORATION INFORMATION
    • 6.5.2 TEVAPHARM DESCRIPTION AND BUSINESS OVERVIEW
    • 6.5.3 TEVAPHARM MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.5.4 TEVAPHARM MESOTHERAPY PRODUCT PORTFOLIO
  • 6.6 CHAMEDITHEC
    • 6.6.1 CHAMEDITHEC CORPORATION INFORMATION
    • 6.6.2 CHAMEDITHEC DESCRIPTION AND BUSINESS OVERVIEW
    • 6.6.3 CHAMEDITHEC MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.6.4 CHAMEDITHEC MESOTHERAPY PRODUCT PORTFOLIO
  • 6.7 DONG KOOK LIFESCIENCE
    • 6.7.1 DONG KOOK LIFESCIENCE CORPORATION INFORMATION
    • 6.7.2 DONG KOOK LIFESCIENCE DESCRIPTION AND BUSINESS OVERVIEW
    • 6.7.3 DONG KOOK LIFESCIENCE MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.7.4 DONG KOOK LIFESCIENCE MESOTHERAPY PRODUCT PORTFOLIO
  • 6.8 HUONS
    • 6.8.1 HUONS CORPORATION INFORMATION
    • 6.8.2 HUONS DESCRIPTION AND BUSINESS OVERVIEW
    • 6.8.3 HUONS MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.8.4 HUONS MESOTHERAPY PRODUCT PORTFOLIO
  • 6.9 BLOOMAGEFREDA
    • 6.9.1 BLOOMAGEFREDA CORPORATION INFORMATION
    • 6.9.2 BLOOMAGEFREDA DESCRIPTION AND BUSINESS OVERVIEW
    • 6.9.3 BLOOMAGEFREDA MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.9.4 BLOOMAGEFREDA MESOTHERAPY PRODUCT PORTFOLIO
  • 6.10 SHANGHAI QISHENG
    • 6.10.1 SHANGHAI QISHENG CORPORATION INFORMATION
    • 6.10.2 SHANGHAI QISHENG DESCRIPTION AND BUSINESS OVERVIEW
    • 6.10.3 SHANGHAI QISHENG MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.10.4 SHANGHAI QISHENG MESOTHERAPY PRODUCT PORTFOLIO
  • 6.11 EVE CHARM
    • 6.11.1 EVE CHARM CORPORATION INFORMATION
    • 6.11.2 EVE CHARM DESCRIPTION AND BUSINESS OVERVIEW
    • 6.11.3 EVE CHARM MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.11.4 EVE CHARM MESOTHERAPY PRODUCT PORTFOLIO
  • 6.12 PAVAY
    • 6.12.1 PAVAY CORPORATION INFORMATION
    • 6.12.2 PAVAY DESCRIPTION AND BUSINESS OVERVIEW
    • 6.12.3 PAVAY MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.12.4 PAVAY MESOTHERAPY PRODUCT PORTFOLIO
  • 6.13 SUNMAX BIOTECH
    • 6.13.1 SUNMAX BIOTECH CORPORATION INFORMATION
    • 6.13.2 SUNMAX BIOTECH DESCRIPTION AND BUSINESS OVERVIEW
    • 6.13.3 SUNMAX BIOTECH MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.13.4 SUNMAX BIOTECH MESOTHERAPY PRODUCT PORTFOLIO
  • 6.14 IMEIK
    • 6.14.1 IMEIK CORPORATION INFORMATION
    • 6.14.2 IMEIK DESCRIPTION AND BUSINESS OVERVIEW
    • 6.14.3 IMEIK MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.14.4 IMEIK MESOTHERAPY PRODUCT PORTFOLIO

7 MESOTHERAPY MANUFACTURING COST ANALYSIS

  • 7.1 MESOTHERAPY KEY RAW MATERIALS ANALYSIS
    • 7.1.1 KEY RAW MATERIALS
    • 7.1.2 KEY SUPPLIERS OF RAW MATERIALS
  • 7.2 PROPORTION OF MANUFACTURING COST STRUCTURE
  • 7.3 MANUFACTURING PROCESS ANALYSIS OF MESOTHERAPY
  • 7.4 MESOTHERAPY INDUSTRIAL CHAIN ANALYSIS

8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS

  • 8.1 MARKETING CHANNEL
  • 8.2 MESOTHERAPY DISTRIBUTORS LIST
  • 8.3 MESOTHERAPY CUSTOMERS ANALYSIS

9 MESOTHERAPY MARKET DYNAMICS

  • 9.1 MESOTHERAPY INDUSTRY TRENDS
  • 9.2 MESOTHERAPY MARKET DRIVERS
  • 9.3 MESOTHERAPY MARKET CHALLENGES
  • 9.4 MESOTHERAPY MARKET RESTRAINTS

10 GLOBAL MARKET FORECAST

  • 10.1 MESOTHERAPY MARKET ESTIMATES AND PROJECTIONS BY TYPE
    • 10.1.1 GLOBAL FORECASTED SALES OF MESOTHERAPY BY TYPE (2023-2028)
    • 10.1.2 GLOBAL FORECASTED REVENUE OF MESOTHERAPY BY TYPE (2023-2028)
  • 10.2 MESOTHERAPY MARKET ESTIMATES AND PROJECTIONS BY APPLICATION
    • 10.2.1 GLOBAL FORECASTED SALES OF MESOTHERAPY BY APPLICATION (2023-2028)
    • 10.2.2 GLOBAL FORECASTED REVENUE OF MESOTHERAPY BY APPLICATION (2023-2028)
  • 10.3 MESOTHERAPY MARKET ESTIMATES AND PROJECTIONS BY REGION
    • 10.3.1 GLOBAL FORECASTED SALES OF MESOTHERAPY BY REGION (2023-2028)
    • 10.3.2 GLOBAL FORECASTED REVENUE OF MESOTHERAPY BY REGION (2023-2028)

11 RESEARCH FINDINGS AND CONCLUSION

12 METHODOLOGY AND DATA SOURCE

  • 12.1 METHODOLOGY/RESEARCH APPROACH
    • 12.1.1 RESEARCH PROGRAMS/DESIGN
    • 12.1.2 MARKET SIZE ESTIMATION
    • 12.1.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 12.2 DATA SOURCE
    • 12.2.1 SECONDARY SOURCES
    • 12.2.2 PRIMARY SOURCES
  • 12.3 AUTHOR LIST
  • 12.4 DISCLAIMER 92